[Current treatment of leprosy in the Malta pavilion of the Hôpital Saint-Louis].
D000553:Ambulatory Care; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D005602:France; D006760:Hospitalization; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000601:surgery; D012293:Rifampin / Q000627:therapeutic use*; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use*; D013792:Thalidomide / Q000627:therapeutic use*; D013890:Thiourea / Q000031:analogs & derivatives*
D000890:Anti-Infective Agents; D013792:Thalidomide; D003622:Dapsone; D013890:Thiourea; D013421:Sulfamethoxypyridazine; D012293:Rifampin
Le traitement actuel de la lépre au pavillon de Malte de l'hôpital Saint-Louis